Point72 Asset Management
IDXX icon

Point72 Asset Management’s Idexx Laboratories IDXX Stock Holding History

Point72 Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,500
Closed -$805K – 2495
2025
Q2 		$805K Hold
1,500
– – ﹤0.01% 1631
2025
Q1 		$630K Sell
1,500
-5,100
-77% -$2.21M ﹤0.01% 1561
2024
Q4 		$2.73M Buy
6,600
+1,600
+32% +$702K 0.01% 1144
2024
Q3 		$2.53M Sell
5,000
-600
-11% -$291K 0.01% 1098
2024
Q2 		$2.73M Buy
+5,600
New +$2.81M 0.01% 1005

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Point72 Asset Management's IDXX Position: Q1 2026 in Review

Point72 Asset Management increased its Idexx Laboratories (IDXX) stake by 1,054% in Q1 2026, buying an estimated $75.7M and bringing the position to 129,284 shares worth $72.6M. The position accounts for 0.09% of the portfolio, ranked #248.

Point72 Asset Management first reported a position in IDXX in Q1 2015 and has held it in 16 quarters since. The position peaked at $78M in Q4 2023. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Point72 Asset Management held 129,284 shares of Idexx Laboratories worth $72.6M as of Q1 2026.
  • Point72 Asset Management bought 118,080 Idexx Laboratories shares in Q1 2026, an estimated $75.7M.
  • Idexx Laboratories made up 0.09% of Point72 Asset Management's portfolio in Q1 2026, its #248 holding.
  • Point72 Asset Management first reported a position in Idexx Laboratories in Q1 2015 and has held it in 16 quarters since.
  • Point72 Asset Management's Idexx Laboratories position peaked at $78M in Q4 2023.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.